KSQ Therapeutics, Inc
KSQ has industrialized genome-wide CRISPR/Cas9 functional genomic screens across a wide array of cancer models and immune cell types, seeking to identify the genome’s top therapeutic targets. Partnership potential with TILS, CAR-Ts, TCR-Ts, TRegs.
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}